• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】F-1394

【化学名称】N-(2,2,5,5-Tetramethyl-1,3-dioxan-4-ylcarbonyl)-beta-alanine 2(S)-[N'-(2,2-dimethylpropyl)-N'-nonylureido]-1(S)-cyclohexyl ester

【CA登记号】135392-43-7

【 分 子 式 】C33H61N3O6

【 分 子 量 】595.87062

【开发单位】UCB Japan (Originator)

【药理作用】Atherosclerosis Therapy, CARDIOVASCULAR DRUGS, Lipoprotein Disorders, Treatment of , METABOLIC DRUGS, Treatment of Disorders of the Coronary Arteries and Atherosclerosis, ACAT Inhibitors

合成路线1

By esterification of the acetonide of pantothenic acid (I) with (1S,2S)-2-[3-(2,2-dimethylpropyl)-3-nonylureido]-cyclohexanol (II) by means of dimethylaminopyridine (DMAP) and tosyl chloride in ethyl acetate (1) or DMAP and dicyclohexylcarbodiimide (DCC) in refluxing toluene (2). The starting compounds (I) and (II) have been prepared as follows: 1) The cyclization of pantothenic acid calcium salt (III) with 2,2-dimethoxypropane (IV) by means of oxalic acid and p-toluenesulfonic acid in refluxing acetones gives the acetonide (I). 2) The condensation of the carbamate (V) with the secondary amine (VI) by heating at 120 C yields the urea derivative (II).

1 Ikawa, H.; Matsumoto, H.; Kobayashi, N.; Kusunoki, J. (UCB Japan); Pantothenic acid derivs. EP 0421441; JP 1991218340; JP 1991218350; JP 1991218366; US 5120738 .
2 Ikawa, H.; Matsumoto, H. (UCB Japan); Methods of producing pantothenic acid deriv. and its starting materials for producing the same. EP 0612740 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17387 3-[[(2,2,5,5-tetramethyl-1,3-dioxan-4-yl)carbonyl]amino]propionic acid C12H21NO5 详情 详情
(II) 17388 N'-[(1S,2S)-2-hydroxycyclohexyl]-N-neopentyl-N-nonylurea C21H42N2O2 详情 详情
(III) 17389 3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoate C18H32N2O10 详情 详情
(IV) 10722 1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane 77-76-9 C5H12O2 详情 详情
(V) 17391 phenyl N-[(1S,2S)-2-hydroxycyclohexyl]carbamate C13H17NO3 详情 详情
(VI) 17392 N-neopentyl-1-nonanamine; N-neopentyl-N-nonylamine C14H31N 详情 详情
Extended Information